Fathom Holdings Announces Closing of Underwritten Public Offering of Common Stock

Fathom Holdings Inc. (Nasdaq: FTHM), a national, technology-driven real estate services platform, today announced the closing of its previously announced underwritten public offering of 3,000,000 shares of its common stock at a price of $2.00 per share. https://mma.prnewswire.com/media/1094751/Fathom_Realty_Logo.jpg The Company also granted the underwriter of the offering a 45-day option to purchase up to an […]

Definity Chief Executive Officer Rowan Saunders to participate in fireside chat at 24th annual CIBC Eastern Institutional Investor Conference

Rowan Saunders, President and Chief Executive Officer ofDefinity Financial Corporation (TSX: DFY), will participate in a fireside chat as part of the 24th Annual CIBC Eastern Institutional Investor Conference on Thursday, September 25, 2025 at 8:35 a.m. ET. To access the webcast, please visit: www.definityfinancial.com/English/investors/events-and-presentations/ The full webcast will be archived on our website for

Urgently Receives Nasdaq Notice of Non-Compliance

Urgently Receives Nasdaq Notice of Non-Compliance Intends to Request Hearing GlobeNewswire September 22, 2025 ASHBURN, Va., Sept. 22, 2025 (GLOBE NEWSWIRE) — Urgent.ly Inc. (Nasdaq: ULY) (“Urgently” or the “Company”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, announced today that The Nasdaq Stock Market LLC (“Nasdaq”) formally notified the

Financial Institutions, Inc. Announces New Share Repurchase Program

Financial Institutions, Inc. Announces New Share Repurchase Program GlobeNewswire September 22, 2025 WARSAW, N.Y., Sept. 22, 2025 (GLOBE NEWSWIRE) — Financial Institutions, Inc. (NASDAQ: FISI) (the “Company”), the parent company of Five Star Bank and Courier Capital, LLC, today announced that its Board of Directors (the “Board”) has approved a new share repurchase program for

J-Star Holding Names Sam Van as Chief Executive Officer

J-Star Holding Names Sam Van as Chief Executive Officer GlobeNewswire September 22, 2025 TAICHUNG CITY, Taiwan, Sept. 22, 2025 (GLOBE NEWSWIRE) — J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of applications including personal sports equipment, healthcare products, automobile

Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform

Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform AI-Powered Heartflow Plaque Analysis to be Covered by Cigna Health Plans Nationwide GlobeNewswire September 22, 2025 MOUNTAIN VIEW, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) — Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today

Galata Acquisition Corp. II Completes $172.5 Million Initial Public Offering

Galata Acquisition Corp. II Completes $172.5 Million Initial Public Offering GlobeNewswire September 22, 2025 Nashville, Tennessee, Sept. 22, 2025 (GLOBE NEWSWIRE) — Galata Acquisition Corp. II (the “Company”) announced today the closing of its initial public offering of 17,250,000 units, which includes 2,250,000 units issued pursuant to the exercise by the underwriters of their over-allotment

Coherent Unveils a Family of Integrated Circuits for Next-Generation Optical Transceivers

Coherent Unveils a Family of Integrated Circuits for Next-Generation Optical Transceivers GlobeNewswire September 22, 2025 SAXONBURG, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced a new family of quad-channel integrated circuits that enable faster, more efficient optical transceivers for cloud, AI, and telecom networks. Coherent

ArriVent Appoints Brent S. Rice as Chief Commercial Officer

ArriVent Appoints Brent S. Rice as Chief Commercial Officer GlobeNewswire September 22, 2025 NEWTOWN SQUARE, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) — ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of Brent S. Rice as Chief Commercial Officer

Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update

Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update GlobeNewswire September 22, 2025 Interim Clinical Study Results for Cohort 1 of the BB-301 Phase 1b/2a Treatment Study Anticipated in Q4 2025 Enrollment of the First Subject into Cohort 2 of the BB-301 Phase 1b/2a Treatment Study Expected in Q4 2025 HAYWARD, Calif.,

Scroll to Top